■Abstract Submission Period
noon of June 15 (Thu) – noon of July 20 (Thu)  noon of July 27 (Thu) 

noon of August 3 (Thu) ,2023 (UTC+9)

The deadline for abstract submissions for general presentations has been extended.

Abstract submission has been closed.
Thank you for your submission.

■Abstract Submission Guidelines
How to write Abstract
1. All abstract must be written by in English and Presentations must be delivered 
　in English.
2. The content of the abstract is solely the responsibility of the author, 
　and any published articles will not be accepted.
3. In preparation of the abstract, please adopt the following structured format:
　[Oral Presentation & Poster Presentation] 
　　→Objectives - Methods - Results - Conclusions
　[Oral case study presentation] 
　　→Objectives - Case Description - Conclusions
4. Do not include author information such as affiliation and title in the abstract body.
5. All abbreviations must be defined at the first time they appear before being used 
　as an abbreviation in the text.
6. The title should NOT contain more than 100 characters and must be submitted 
　in English.
7. The body of the abstract should NOT exceed more than 1,600 characters for 
　Oral presentation and Poster presentation  and 800 characters for Oral case 
　study presentation. 
　It must be submitted in English.
8. Abstracts should NOT contain references, figures, tables or diagrams.
 
Preferred Presentation Type
Please select at least one presentation type;
- Oral Presentation
- Poster Presentation
- Oral case study presentation
 
The type of presentation for submitted abstracts will be selected based on the 
results of peer review.
 
How to Submit Abstracts
All abstracts must be submitted online via this website. 
Please click the button at the top of this page.
Please note that abstracts submitted by email or post will not be considered or 
reviewed.
*It is authors' responsibility to review and proofread the submissions.
*Submitters are responsible for every typing error on the abstract.
 
Please enter the title of your presentation within the character limit displayed by 
the boxes.
Please make sure there is no mistake with the title since the text entered is going 
to be used for the conference web site and printed proceedings as is.
 
Confirmation and Modification
After completing your registration, you will receive a confirmation email.
If you do not receive a confirmation email, you may have entered a wrong email 
address or may have failed to complete your registration, or a confirmation email 
might be sorted as a spam email.
If this happens, please search for emails sent from "@atlas.jp" in your mail-box, 
or contact the Congress Secretariat by email.
 
You can confirm and modify your abstract at any time during the abstract 
submission period.
Should you have any questions, please contact the Congress Secretariat by email.
 
Category
1) Prostate cancer
2) Urothelial cancer 
　(Bladder cancer, Upper tract urothelial cancer)
3) Renal cancer
4) Other malignancy or tumors 
　(Testicular cancer, Penile cancer, Rare urologic cancers, Adrenal tumors)
5) Benign disease 
　(Voiding dysfunction, Andrology, Urinary tract infections, Kidney stones, 
　 Renal transplantation, Pediatric urology, Other benign conditions)
 

Questions/Contact Information for Abstract Submission
For abstract-related questions, please contact:
THE 39TH JAPAN-KOREA UROLOGICAL CONGRESS Congress Secretariat
c/o BlueRidge, Inc.　
3-1-17, Nishiazabu, Minato-ku, Tokyo 106-0031, JAPAN
TEL：+81-3-6455-4338　FAX：+81-3-6455-4339　
MAIL：jkuro2023@blue-ridge.jp